articleTop 1% cited
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
The EMBO Journal · 1997 · Vol. 16(7) · pp. 1647–1655
Diana Graus-Porta✉(Friedrich Miescher Institute)
HER2/EGFR in Cancer ResearchCell Adhesion Molecules ResearchMonoclonal and Polyclonal Antibodies ResearchBiologyMediatorReceptorCell biologySignal transductionErbBCancer researchComputational biologyGenetics
MeSH terms
Epidermal Growth FactorFemaleGlycoproteinsGrowth SubstancesHumansKineticsModels, BiologicalModels, StructuralRecombinant ProteinsTransfectionTumor Cells, CulturedVulvar NeoplasmsSignal TransductionDown-RegulationCalcium-Calmodulin-Dependent Protein Kinases
Citations
1,569
FWCI
23.54
field-weighted impact
References
60
Percentile
100%
vs. same field & year
Citations per year
Cited by
ErbB receptors and signaling pathways in cancer
Current Opinion in Cell Biology · 2009 · 975 citations
Epidermal growth factor receptors: critical mediators of multiple receptor pathways
Current Opinion in Cell Biology · 1999 · 607 citations
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Cellular and Molecular Life Sciences · 2008 · 756 citations
Epidermal growth factor receptor: mechanisms of activation and signalling
Experimental Cell Research · 2003 · 1,552 citations
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
The EMBO Journal · 2000 · 2,432 citations
Herceptin: mechanisms of action and resistance
Cancer Letters · 2005 · 440 citations
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
The Journal of Pathology · 2003 · 591 citations
Untangling the ErbB signalling network
Nature Reviews Molecular Cell Biology · 2001 · 6,890 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.